DSIP 5mg

$25.00

DSIP is a naturally occurring neuropeptide first isolated in 1977 from rabbit brains.
It’s composed of 9 amino acids (a nonapeptide) and found in various brain regions, blood plasma, and peripheral organs.
Its name comes from its original discovery: it was thought to promote delta-wave sleep (deep sleep).
Available today mostly through compounding or research supply, since it’s not FDA-approved as a medication.

⚙️ Mechanisms of Action (Proposed)

Research suggests DSIP has multiple neuromodulatory roles, though its exact mechanism is still not fully understood:

Sleep regulation → May promote delta-wave activity, deeper restorative sleep, and circadian rhythm balance.
Endocrine modulation → Influences secretion of LH (luteinizing hormone), ACTH, and may regulate cortisol and melatonin cycles.
Neuroprotection → Reduces oxidative stress and stabilizes neuronal membranes.
Pain & stress response → May act on opioid peptide systems and modulate stress-related hormones.
Immune support → Shows some immunomodulatory effects in preclinical models.

👉 Evidence is mixed—some studies show benefits, others inconclusive.

Generally reported as well tolerated.
Side effects: mild fatigue, headache, vivid dreams, or slight dizziness in some individuals.
Long-term safety data is lacking.
Not recommended in pregnant or breastfeeding women, or in those with severe endocrine disorders, unless supervised by a physician.

DSIP = 9-amino acid peptide studied for its role in sleep regulation, stress reduction, and neuroprotection.
Dosing: usually 100–500 mcg subQ before bedtime, from a 10 mg vial.
Evidence: Some promising results for sleep and stress, but research is limited and not conclusive.
Status: Experimental, not FDA-approved, available mainly as a research peptide.

Quantity:

DSIP is a naturally occurring neuropeptide first isolated in 1977 from rabbit brains.
It’s composed of 9 amino acids (a nonapeptide) and found in various brain regions, blood plasma, and peripheral organs.
Its name comes from its original discovery: it was thought to promote delta-wave sleep (deep sleep).
Available today mostly through compounding or research supply, since it’s not FDA-approved as a medication.

Research suggests DSIP has multiple neuromodulatory roles, though its exact mechanism is still not fully understood:

Sleep regulation → May promote delta-wave activity, deeper restorative sleep, and circadian rhythm balance.
Endocrine modulation → Influences secretion of LH (luteinizing hormone), ACTH, and may regulate cortisol and melatonin cycles.
Neuroprotection → Reduces oxidative stress and stabilizes neuronal membranes.
Pain & stress response → May act on opioid peptide systems and modulate stress-related hormones.
Immune support → Shows some immunomodulatory effects in preclinical models.

👉 Evidence is mixed—some studies show benefits, others inconclusive.

Generally reported as well tolerated.
Side effects: mild fatigue, headache, vivid dreams, or slight dizziness in some individuals.
Long-term safety data is lacking.
Not recommended in pregnant or breastfeeding women, or in those with severe endocrine disorders, unless supervised by a physician.

DSIP = 9-amino acid peptide studied for its role in sleep regulation, stress reduction, and neuroprotection.
Dosing: usually 100–500 mcg subQ before bedtime, from a 10 mg vial.
Evidence: Some promising results for sleep and stress, but research is limited and not conclusive.
Status: Experimental, not FDA-approved, available mainly as a research peptide.